Francomano Robert
SEC CIK 1797467 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | Chief Commercial Off | 40.9K | — | — | 3 | 2023-02-02 | 2024-01-22 |
Most active insiders at SLS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kalin Katherine Bach | Dir | $100.8K | — |
| 2 | Stergiou Angelos M. | Pres, CEO, Dir | — | — |
| 3 | Burns John Thomas | CFO | — | — |
| 4 | CICIC DRAGAN | SVP, Chief Development Off | — | — |
| 5 | Varian John | Dir | — | — |
| 6 | Wasman Jane | Dir | — | — |
| 7 | SCHEINBERG DAVID A | Dir | — | — |
| 8 | VAN NOSTRAND ROBERT L | Dir | — | — |
Francomano Robert made no open-market trades at SLS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-25 | 2024-01-22 | SLS | SELLAS Life Sciences Group, Inc. | Francomano Robert | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 40.9K | +96% | $0 |
| 2023-12-08 | 2023-12-06 | SLS | SELLAS Life Sciences Group, Inc. | Francomano Robert | Chief Commercial Off | J - Other | $1.08 | -1,082 | 20.9K | -5% | -$1,169 | |
| D | 2023-02-03 | 2023-02-02 | SLS | SELLAS Life Sciences Group, Inc. | Francomano Robert | Chief Commercial Off | A - Grant | $0.00 | +12.0K | 12.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations